Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Precocious puberty

R R Shankar1, O H Pescovitz

  • 1Department of Pediatrics, Indiana University Medical School, James Whitcomb Riley Hospital for Children, Indianapolis, USA.

Advances in Endocrinology and Metabolism
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

POST OPERATIVE PAIN RELIEF IN CAESAREAN SECTION.

Medical journal, Armed Forces India·2016
Same author

Metformin prescription patterns among US adolescents aged 10-19 years: 2009-2013.

Journal of clinical pharmacy and therapeutics·2016
Same author

A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus.

International journal of clinical practice·2015
Same author

Identification and localization of secretin and secretin receptor mRNAs in rat testis.

Endocrine·2010
Same author

Peptides of the growth hormone-releasing hormone family : Differential expression in rat testis.

Endocrine·2010
Same author

Advances in the treatment of precocious puberty.

Expert opinion on investigational drugs·2002
Same journal

Ambiguous genitalia--etiology, diagnosis, and therapy.

Advances in endocrinology and metabolism·1995
Same journal

Unusual variants of papillary thyroid carcinoma.

Advances in endocrinology and metabolism·1995
Same journal

Brittle diabetes: etiology and treatment.

Advances in endocrinology and metabolism·1995
Same journal

Bisphosphonates in the treatment of disorders of mineral metabolism.

Advances in endocrinology and metabolism·1995
Same journal

Premature ovarian failure.

Advances in endocrinology and metabolism·1995
Same journal

Insulin resistance: the clinical spectrum.

Advances in endocrinology and metabolism·1995
See all related articles

Long-acting GnRH analogues are effective treatments for precocious puberty, slowing development and improving final adult height. Therapy is most beneficial for early-onset cases, rapid bone age advancement, or lower genetic height potential.

Area of Science:

  • Pediatric Endocrinology
  • Reproductive Medicine
  • Genetics

Background:

  • Precocious puberty diagnosis and treatment have advanced significantly.
  • The exact cause of Central Precocious Puberty (CPP) remains unknown.
  • Long-acting Gonadotropin-releasing Hormone (GnRH) analogues are a primary therapeutic option.

Purpose of the Study:

  • To review the efficacy and indications for GnRH analogue therapy in children with precocious puberty.
  • To discuss the impact of therapy on linear growth and adult height.
  • To explore recent molecular insights into specific forms of precocious puberty.

Main Methods:

  • Review of current literature on precocious puberty treatment.
  • Analysis of GnRH analogue therapy outcomes regarding growth and bone maturation.

Related Experiment Videos

  • Discussion of molecular mechanisms in McCune-Albright Syndrome (MAS) and Familial Male Precocious Puberty (FMPP).

    • Main Results:

    • GnRH analogue therapy effectively slows secondary sexual characteristic progression, linear growth, and bone maturation.
    • Achieved adult heights are generally greater than predicted heights before treatment.
    • Treatment is not universally indicated, with careful patient selection based on progression rate and genetic potential.

    Conclusions:

    • GnRH analogue therapy is safe and effective for managing precocious puberty, particularly in early-onset or rapidly progressing cases.
    • While improving final height, the precise long-term benefit requires further evaluation.
    • Understanding molecular defects in MAS and FMPP aids in explaining clinical features, with future research targeting gonadotropin-independent forms.